BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress

被引:85
作者
Farina, A
Feederle, R
Raffa, S
Gonnella, R
Santarelli, R
Frati, L
Angeloni, A
Torrisi, MR
Faggioni, A
Delecluse, HJ
机构
[1] Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy
[2] Azienda Osped St Andrea, Rome, Italy
[3] IRCCS, Ist Dermatol Santa Maria & San Gallicano, Rome, Italy
[4] German Canc Res Ctr, Dept Virus Assoc Tumours, D-6900 Heidelberg, Germany
关键词
D O I
10.1128/JVI.79.6.3703-3712.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The molecular mechanisms that underlie maturation and egress of Epstein-Barr virus (EBV) virions are only partially characterized. We have recently shown that the BFRF1 gene, the EBV positional homolog of herpes simplex virus type I and pseudorabies virus UL34, is expressed early during EBV lytic replication and that it is found predominantly on the nuclear membrane (A. Farina, R. Santarelli, R. Gonnella, R. Bei, R. Muraro, G. Cardinali, S. Uccini, G. Ragona, L. Frati, A. Faggioni, and A. Angeloni, J. Virol. 74:3235-3244, 2000). These data suggest that the BFRF1 protein might be involved in viral primary envelopment. To precisely determine the function of this protein, we have constructed an EBV mutant devoid of the BFRF1 gene (BFRF1-KO). 293 cells carrying BFRF1-KO showed no differences in comparison with wild-type EBV in terms of DNA lytic replication or expression of late viral proteins upon induction of the lytic cycle. However, binding assays and infection experiments using cell lines or human cord blood lymphocytes showed a clear reduction in the viral mutant titers. Complementation experiments with BFRF1-KO and a BFRF1 expression vector restored viral titers to levels similar to those for the wild-type control, showing that the modifications that we introduced were limited to the BFRF1 gene. Electron microscopic observations showed that the reduction in viral titers was due to sequestration of EBV nucleocapsids in the nuclei of lytically induced cells. This suggests that BFRF1 is involved in transport of the maturing virion across the nuclear membrane. This hypothesis was further supported by the observation that BFRF1 is present in maturing intracellular virions but not in their extracellular counterparts. This implies that BFRF1 is a key protein for EBV maturation.
引用
收藏
页码:3703 / 3712
页数:10
相关论文
共 55 条
[1]   Epstein-Barr virus and breast cancer: Search for antibodies to the novel BFRF1 protein in sera of breast cancer patients [J].
Angeloni, A ;
Farina, A ;
Gentile, G ;
Capobianchi, A ;
Martino, P ;
Visco, V ;
Muraro, R ;
Frati, L ;
Faggioni, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (07) :560-561
[2]   ESTABLISHMENT IN CONTINUOUS CULTURE OF A NEW TYPE OF LYMPHOCYTE FROM A BURKITT-LIKE MALIGNANT-LYMPHOMA (LINE DG-75) [J].
BENBASSAT, H ;
GOLDBLUM, N ;
MITRANI, S ;
GOLDBLUM, T ;
YOFFEY, JM ;
COHEN, MM ;
BENTWICH, Z ;
RAMOT, B ;
KLEIN, E ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1977, 19 (01) :27-33
[3]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[4]   GENE DISRUPTION IN ESCHERICHIA-COLI - TCR AND KM(R) CASSETTES WITH THE OPTION OF FLP-CATALYZED EXCISION OF THE ANTIBIOTIC-RESISTANCE DETERMINANT [J].
CHEREPANOV, PP ;
WACKERNAGEL, W .
GENE, 1995, 158 (01) :9-14
[5]   A 2ND EPSTEIN-BARR VIRUS EARLY ANTIGEN GENE IN BAMHI FRAGMENT-M ENCODES A 48-KILODALTON TO 50-KILODALTON NUCLEAR-PROTEIN [J].
CHO, MS ;
MILMAN, G ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1985, 56 (03) :860-866
[6]   Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype [J].
Chodosh, J ;
Bolder, VP ;
Gan, YJ ;
Belgaumi, A ;
Sample, J ;
Sixbey, JW .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1194-1201
[7]   EPSTEIN-BARR-VIRUS INTERNALIZATION AND INFECTIVITY ARE BLOCKED BY SELECTIVE PROTEIN KINASE-C INHIBITORS [J].
CIRONE, M ;
ANGELONI, A ;
BARILE, G ;
ZOMPETTA, C ;
VENANZONI, M ;
TORRISI, MR ;
FRATI, L ;
FAGGIONI, A .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :490-493
[8]   THE LYTIC CYCLE OF EPSTEIN-BARR-VIRUS IN THE NONPRODUCER RAJI LINE CAN BE RESCUED BY THE EXPRESSION OF A 135-KILODALTON PROTEIN ENCODED BY THE BALF2 OPEN READING FRAME [J].
DECAUSSIN, G ;
LECLERC, V ;
OOKA, T .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7309-7314
[9]   Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells [J].
Delecluse, HJ ;
Hilsendegen, T ;
Pich, D ;
Zeidler, R ;
Hammerschmidt, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8245-8250
[10]  
Epstein M.A., 1979, EPSTEIN BARR VIRUS, P23